Adynxx, Inc. Receives Nasdaq Notice of Delisting or Failure to Satisfy an Initial Listing Rule or Standard

World News: . []

SAN FRANCISCO May 09 2019 GLOBE NEWSWIRE -- LINK  Inc NasdaqADYX a clinical-stage biopharmaceutical company leading the development of transcription LINK  decoy technology and first-in-class therapeutics for the treatment of pain and i nflamma...

More news and information about Adynxx, Inc.

Published By:

Globe Newswire: 22:30 GMT Thursday 9th May 2019

Published: .

Search for other references to "adynxx" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us